Report : South America Blood Brain Barrier Technologies Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Technology (Bispecific Antibody RMT Approach, Trojan Horse Approach, Increasing Permeability, Passive Diffusion, and Other Non-Invasive BBB Technologies) and Application (Alzheimer’s Disease, Epilepsy, Parkinson’s Disease, Multiple Sclerosis, Hunter’s Syndrome, Brain Cancer, and Others)
Parkinson’s disease Segment to dominate South America Blood Brain Barrier Technologies Market during 2021–2028
According to a new market research study on “South America Blood Brain Barrier Technologies Market to 2028 – COVID-19 Impact and Regional Analysis and Forecast by Technology and Application,” is expected to reach US$ 297.18 million by 2028 from US$ 64.02 million in 2021. The market is estimated to grow at a CAGR of 24.5% from 2021 to 2028. The report provides trends prevailing in the South America blood brain barrier technologies market along with the drivers and restraints pertaining to the market growth. Elevating number of product approvals and launches, boosting prevalence of neurological disorders, and surging demand nanoparticles for brain drug delivery are the major factor driving the growth of the South America blood brain barrier technologies market. However, barriers in brain medication delivery hinders the growth of South America blood brain barrier technologies market.
The presence of various developing countries in South America makes this region one of the key markets for the future growth of the blood brain barrier technologies market. The growing population, rising disposable income, growing awareness related to daily health diagnostics, and rise in prevalence of neurological diseases are some of the key factors that are expected to drive the growth and demand for blood brain barrier technologies treatment in this region. However, the high number of confirmed cases and deaths due to COVID-19 in major South American countries such as Brazil, Peru, Chile, Ecuador, and Argentina are anticipated to affect the market demand in these countries. Headache, fever, anosmia, ageusia, as well as encephalitis, Guillain-Barre syndrome, and ischemic stroke have all been linked to infection with the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). SARS-CoV-2, which is responsible for the current coronavirus disease (COVID-19) pandemic, can enter and affect the central nervous system (CNS) through a variety of routes, including axonal retrograde transport or interactions with the blood-brain barrier (BBB) or blood-cerebrospinal fluid (CSF) barrier. It observed low replication of SARS-CoV-2 that was accompanied by a very moderate inflammatory response. All these factors are expected to positive impact the growth of blood brain barrier technologies market in this region in the coming quarters.
The South America blood brain barrier technologies market is segmented on the basis of technology, application, and country. Based on technology, the blood brain barrier technologies market is segmented into bispecific antibody RMT approach, trojan horse approach, increasing permeability, passive diffusion, and other non-invasive BBB technologies. In 2021, increasing permeability segment held the largest share in the market, and it is also expected to be the fastest growing segment during the forecast period. On the basis of application, the blood brain barrier technologies market is segmented into alzheimer’s disease, epilepsy, parkinson’s disease, multiple sclerosis, hunter’s syndrome, brain cancer, and others. In 2021, parkinson’s disease segment held the largest share in the market, and epilepsy is expected to be the fastest growing segment during the forecast period. Similarly, Based on country the market is segmented into Brazil, Argentina, and Rest of SAM. In 2021, Brazil held the largest share in the market, and it is also expected to be the fastest growing country during the forecast period.
Teva Pharmaceutical Industries Ltd.; F. Hoffmann-La Roche Ltd.; Eli Lilly and Company; Bristol-Myers Squibb Company; Pfizer, Inc.; and Johnson & Johnson Services, Inc. are among the leading companies in the South America blood brain barrier technologies market. The companies are focused on adopting organic growth strategies such as product launches and expansions to sustain their position in the dynamic market.
Contact Person: Sameer Joshi
Email Id: email@example.com